Recent Press Releases

Roche expands HIV Global Access Program to include infants in resource limited settings

Program adds early infant testing to further support the 90:90:90 UNAIDS goal

EISAI ENTERS AGREEMENT TO TRANSFER NORTH CAROLINA PLANT IN THE U.S. TO BIOGEN

EISAI ENTERS AGREEMENT TO TRANSFER NORTH CAROLINA PLANT IN THE U.S. TO BIOGEN July 16, 2015 - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that its U.S....

Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

THOUSAND OAKS, Calif., July 16, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the top-line results of a Phase 2 open-label, single-arm, multicenter trial to evaluate the efficacy and...

Valeant Pharmaceuticals Agrees To Acquire Amoun Pharmaceutical

LAVAL, Quebec , July 17, 2015 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that it has entered into a definitive agreement under which Valeant will...

Amgen Announces Positive BLINCYTO® (blinatumomab) Phase 2 Study Results In Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

THOUSAND OAKS, Calif., July 16, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the top-line results of a Phase 2 o

GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed

- Supply shifts to 100% four-strain vaccines

PHILADELPHIA, July 16, 2015 /PRNewswire/ -- GSK (L

GSK Press Release: GSK begins shipping 2015-16 US flu vaccines with focus on customer needs, volume, and speed

Supply shifts to 100% four-strain vaccines - 32-38 million doses expected, an increase over last year GSK [LSE/NYSE: GSK] announced today it has begun shipping FLUARIX® QUADRIVALENT (Influenza...

NEJM: Analysis of Delamanid (Deltyba™) Data Shows Positive Efficacy Results for Treatment of XDR-TB

Analysis of data from Phase IIb trial showed that delamanid plus a background regimen may be a promising treatment option in complex, difficult-to-treat XDR-TB patients.i · Delamanid...

Novartis malaria treatment Coartem(R) 80/480mg receives WHO prequalification, enabling greater access for patients

WHO prequalified Coartem® 80/480mg is the first and only high strength malaria treatment available for donor-funded public sector procurement Coartem® 80/480mg reduces the pill burden for...

Award-Winning Actress S. Epatha Merkerson, Merck and the American Diabetes Association Challenge African Americans with Type 2 Diabetes to Get to Their A1C Goal

Merkerson Visits Raleigh on July 15 as Part of America's Diabetes Challenge: Get to Your Goals Program

KENILWORTH, N.J.,

SANOFI ANNOUNCES NEW, GLOBAL BUSINESS UNIT STRUCTURE TO DRIVE FUTURE GROWTH

Deepens specialization and allows clear focus on growth drivers Three, new Global Business Units for General Medicines & Emerging Markets, Specialty Care, and Diabetes & Cardiovascular...

Ardelyx to Provide Updates on Research and Development Programs at Today's Inaugural R&D Day in New York City

Tenapanor development plans will be presented along with new data demonstrating sustained response in IBS-C

FREMONT, Calif.,

Bayer receives European approval for Gadovist® (gadobutrol) for use in pediatric patients less than 2 years of age

Leverkusen, July 14, 2015 – Bayer HealthCare announced today that Gadovist® (gadobutrol) has received a label extension in the European Union (EU) for diagnostic use with magnetic resonance...

Consumer and Public Interest Groups Write To FTC Opposing Teva's Hostile Takeover of Mylan

Washington, D.C. – Today, consumer advocacy groups including Consumers Union, Consumer Federation of America, US PIRG, Consumer Action, Consumer Watchdog, Public Citizen, and National Center...

IRESSA APPROVED BY US FDA FOR FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER

IRESSA APPROVED BY US FDA FOR FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED EGFR MUTATION-POSITIVE NON-SMALL CELL LUNG CANCER 13 July 2015 AstraZeneca today announced that the US Food and Drug...

Cummings and Sanders Urge States to Combat Overcharging for Critical Drug Used by First Responders

For Immediate Release July 13, 2015 Contact Jennifer Werner (Cummings): 202-226-5181 Michael Briggs (Sanders): 202-224-5141 Cummings and Sanders Urge States to...

Mylan One of First to Launch Generic Version of Namenda(R) Tablets

Company awarded 180 days shared marketing exclusivity - HERTFORDSHIRE, England and PITTSBURGH, July 14, 2015 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today announced the U.S. launch of Memantine...

Johnson & Johnson Reports 2015 Second-Quarter Results

Sales of $17.8 Billion Decreased 8.8% Versus 2014 Second Quarter Second-Quarter EPS was $1.61 Adjusted 2015 Second-Quarter EPS of $1.71 Decreased 3.9%* Solid Underlying Growth Offset by Currency and...

GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries

The Francis Crick Institute, the UK's newest biomedical research facility, and GSK, the UK's largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues...